Tag: Adverum Biotechnologies (ADVM)

Editas, Adverum and Spark: Novel Gene Editing and Viral Vectors Make Gene Therapy Achievable

Editas, Adverum and Spark: Novel Gene Editing and Viral Vectors Make Gene Therapy Achievable

Gene Editing EDITAS MEDICINE CRISPR gene editing firm Editas Medicine (EDIT) signed a collaboration agreement with a   small cap gene therapy firm called Adverum Biotechnologies (ADVM). The collaboration aims at exploring the delivery of Editas’ genome editing approach with Adverum’s next-generation adeno-associated viral (AAV) vectors to treat up to five inherited retinal diseases that have yet to find treatments or have poor existing remedies. According …